Nimbus, Belcher, Khalil & More: Innovation at the Intersection Award Finalists
Home
Our Approach
Pipeline & Targets
→
← Back
/ Pipeline & Targets /
Pipeline & Targets Overview
Our Pipeline
Nimbus Programs
Acquired Programs
Publications & Presentations
News & Events
Culture & Careers
About Us
→
← Back
/ About Us /
About Us Overview
Nimbus Leadership
Board of Directors
Investors
Contact Us
Nimbus Therapeutics
Archives:
In the News Items
Nimbus, Belcher, Khalil & More: Innovation at the Intersection Award Finalists
Can Innate Immune System Targets Turn Up the Heat on Cold Tumours?
Nimble Move
Celgene joins the heavyweight partner club collaborating with Nimbus
Don Nicholson of Nimbus: Making It Rain
The drug-maker’s guide to the galaxy
Gormley’s Take: Punching Back at Liver Cancer
Nimbus in full-on drug development partnership with Charles River
New England Venture Capital Association announces 2017 NEVY Awards nominees
Gender tokenism and bias prevail in biotech boardrooms
Posts navigation
Previous page
Page
1
Page
2
Page
3
Page
4
Next page